In the BioHarmony Drug Report Database

"Preview" Icon

Becaplermin

Regranex (becaplermin) is a protein pharmaceutical. Becaplermin was first approved as Regranex on 1997-12-16. It is used to treat diabetic neuropathies in the USA.

 

Trade Name

 

Regranex
 

Common Name

 

becaplermin
 

ChEMBL ID

 

CHEMBL1201556
 

Indication

 

diabetic neuropathies
 

Drug Class

 

Growth factors: platelet derived growth factors

Image (chem structure or protein)

Becaplermin structure rendering